Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Current Cardiology Reports

Issue 6/2011

Content (15 Articles)

Coronary Artery Calcium: Utilization for Primary Prevention of CHD

  • Editorial

Harvey S. Hecht

The ACCOMPLISH Trial: Will First-Line Hypertension Therapy Change?

  • Clinical Trial Report

Matthew J. Sorrentino

Can Catheter-Based Renal Denervation Be Used Safely and Effectively to Substantially Reduce Blood Pressure in Treatment-Resistant Hypertensive Patients?

  • Clinical Trial Report

Suzanne Oparil

Stuck between Goal Achievement and Evidence-based Medicine

  • Clinical Trial Report

Michael H. Davidson

What Is the Blood Pressure Goal for the Elder Patient 75 Years of Age or Older?

  • Hypertension (Matthew Sorrentino, Section Editor)

Gary E. Sander, Thomas D. Giles

What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease?

  • Hypertension (Matthew Sorrentino, Section Editor)

Yazan Khouri, Susan P. Steigerwalt, Mershed Alsamara, Peter A. McCullough

Is There a Role for Measuring Central Aortic Pressure?

  • Hypertension (Matthew Sorrentino, Section Editor)

Yonghong Huan, Raymond Townsend

Should β Blockers No Longer Be Considered First-line Therapy for the Treatment of Essential Hypertension Without Comorbidities?

  • Hypertension (Matthew Sorrentino, Section Editor)

William J. Elliott, W. Kurtis Childers

Can Treating the Diastolic Blood Pressure Below a Certain Value Increase Cardiovascular Risk?

  • Hypertension (Matthew Sorrentino, Section Editor)

Norman M. Kaplan

What is the Role of Aldosterone Excess in Resistant Hypertension and How Should It Be Investigated and Treated?

  • Hypertension (Matthew Sorrentino, Section Editor)

Domenic A. Sica

Familial Hypercholesterolemia: Present and Future Management

  • Open Access
  • Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor)

B. Sjouke, D. M. Kusters, J. J. P. Kastelein, G. K. Hovingh

Apo A-I Modulating Therapies

  • Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor)

Stephen J. Nicholls

The Role of Triglycerides in Atherosclerosis

  • Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor)

Beatriz G. Talayero, Frank M. Sacks

Predictors of Statin Adherence

  • Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor)

Alexander Mauskop, William B. Borden

CETP Inhibition: Does the Future Look Promising?

  • Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor)

Peter P. Toth

Oct 11
Issue: 5/2011
Feb 12
Issue: 1/2012

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME